The global lung cancer surgery market is projected to grow significantly, with its valuation expected to rise from USD 1.4 billion in 2024 to USD 2.5 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of lung cancer worldwide, fueled by the rising number of smokers and advancements in surgical techniques.
Key Market Drivers
- Smoking Epidemic: With approximately 1 billion smokers globally, smoking remains the leading cause of lung cancer, increasing the risk by over 15 times. Smoking is responsible for over 80% of lung cancer-related deaths, making it a critical factor driving demand for surgical interventions.
- Efficacy of Surgical Treatment: Surgery offers a potential cure for lung cancer, especially in its early stages, as it can remove the tumor entirely. This has made lung cancer surgery a preferred option for patients seeking effective treatment.
- Technological Advancements: Innovations in minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, are improving outcomes, reducing recovery times, and increasing patient preference for surgical solutions.
Emerging Trends and Opportunities
- Early Diagnosis and Screening Programs: The expansion of early screening initiatives for high-risk populations is leading to increased identification of operable lung cancer cases, boosting the demand for surgery.
- Improved Surgical Techniques: Advancements in surgical equipment and the adoption of precision techniques are enhancing the success rates of lung cancer surgeries.
- Rising Healthcare Awareness: Growing awareness about the benefits of early diagnosis and surgical intervention is driving more patients to opt for surgical treatment.
Future Outlook
As lung cancer remains a major global health concern, the demand for effective surgical solutions is expected to grow. With advancements in technology and greater access to healthcare, the market for lung cancer surgery is set to expand, providing better outcomes for patients worldwide.
Get Complete Full Report – https://www.futuremarketinsights.com/reports/lung-cancer-surgery-market
Key Takeaways:
- The global lung cancer surgery market is projected to grow from USD 1.4 billion in 2024 to USD 2.5 billion by 2034, at a CAGR of 5.7%.
- Smoking is a significant driver, responsible for over 80% of lung cancer-related deaths and increasing global demand for surgical solutions.
- Early-stage lung cancer patients are increasingly opting for surgery due to its potential to completely remove the tumor and offer a cure.
- Advancements in minimally invasive techniques, such as VATS and robotic surgery, are improving patient outcomes and driving market growth.
Growth Drivers
- High Prevalence of Lung Cancer:
- Smoking remains one of the leading causes of lung cancer, significantly increasing the risk of developing the disease. With around 1 billion smokers globally, the incidence of lung cancer is expected to rise, driving demand for surgical interventions.
- Surgical Options for Treatment:
- Surgery is often the preferred treatment for lung cancer, especially in early stages, as it can potentially remove tumors entirely and offers a chance for a cure.
- Technological Advancements:
- Innovations in surgical techniques, including minimally invasive procedures and robotic-assisted surgeries, are improving patient outcomes and increasing the adoption of surgical interventions.
- Rising Awareness and Screening Programs:
- Increased awareness about lung cancer and advancements in screening methods are leading to earlier diagnoses, which can enhance surgical success rates.
Regional Insights
- India: Expected to emerge as a dominant market with a CAGR of 6.9%, driven by high lung cancer rates and efforts to improve healthcare facilities.
- China: Anticipated to grow at a CAGR of 5.2%, reflecting increasing healthcare investments and a growing patient population.
- North America: Currently leads the market due to advanced healthcare infrastructure and high adoption rates of innovative surgical techniques.
Key Manufacturers in the Lung Cancer Surgery Market
- Asap Endoscopic Products
- Ethicon Inc. (J & J)
- Medtronic Plc.
- Germed USA Inc.
- Teleflex Incorporated
- B. Braun Melsungen AG
- Karl Storz
- Richard Wolf
- Olympus Medical Systems Corp
- Intuitive Surgical Inc.
- Ambu A/S
- PENTAX Medical Company
- FUJIFILM Holdings Corporation
Key Segments of Market Report
By Product:
By product, the market includes thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, surgical energy instruments, advanced energy instruments, advanced bipolar instruments, ultrasonic instruments, basic energy instruments, bipolar instruments, and monopolar instruments.
By Application:
By application, the primary procedures are lobectomy, segmentectomy, wedge resection, and pneumonectomy.
By End-user:
By end-user, the market is divided into hospitals and ambulatory surgical centres.
By Region:
The industry is spread across North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube